Although numerous studies have demonstrated the potential benefits of ChEIs, the use of these drugs in clinical practice has not been well described and may differ from that in clinical trials. In ...

Geriatrics and Aging. 2009;12(4):202-207. © 2009 1453987 Ontario, Ltd. Cite this: Practical Approach to the Use of Cholinesterase Inhibitors in Patients With Early ...

In no case, however, has it been shown that treatments with organophosphorus compounds resulted in a selection of individuals with a modified cholinesterase (ChE), which is known to be the actual ...

Eisai develops and sells drugs to treat Alzheimer's dementia, including cholinesterase inhibitor Aricept (donepezil) and Biogen-partnered Aduhelm (aducanumab), which was registered in the US last ...

The global Alzheimer’s therapeutics market revenue was valued at US$ 6.5 billion in 2021 and is projected to reach US$ 13.6 billion by 2031. The market will register a CAGR (Compound Annual Growth ...

Aricept (donepezil) is a prescription drug approved to treat dementia related to Alzheimer’s disease. Aricept comes as a tablet that you swallow. It’s usually taken once per day. Aricept ...